Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
20 Oct 2004
UCB confirms third quarter Zyrtec sales in the US / 6% Increase in European Allergy Franchise
Read More
18 Oct 2004
UCB appoints Chief Financial Officer
Read More
1 Oct 2004
UCB sells Surface Specialties to Cytec for € 1.5 billion
Read More
30 Sep 2004
UCB: Closing of the sale of its films business
Read More
21 Sep 2004
UCB Pharma outlines positive preliminary results from second pivotal CDP 870 Phase III trial in rheumatoid arthritis
Read More
3 Sep 2004
Georges Jacobs announces that he will resign from his executive post on January 1, 2005
Read More
2 Sep 2004
Sale of an industrial site in France
Read More
26 Aug 2004
Reorganisation of research
Read More
29 Jul 2004
Net profit increases by 34%
Read More
19 Jul 2004
UCB has signed an agreement to sell its Films business
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
101
Page
102
Page
103
Page
104
Page
105
Current page
106
Page
107
Page
108
Page
109
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss